MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 190 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $444,744 | -56.7% | 13,008 | -68.2% | 0.02% | -60.0% |
Q1 2024 | $1,026,504 | +64.3% | 40,864 | +93.0% | 0.04% | +48.1% |
Q4 2023 | $624,938 | -14.2% | 21,170 | -8.2% | 0.03% | -32.5% |
Q3 2023 | $728,570 | +33.4% | 23,056 | +9.2% | 0.04% | +37.9% |
Q2 2023 | $546,271 | +42.1% | 21,116 | +31.9% | 0.03% | +20.8% |
Q1 2023 | $384,536 | – | 16,009 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |